|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02192 MEDLIVE
Nominal 
9.210 +0.160 (+1.768%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 412,004 | 31.189% | 314,054 | 284,440 | 213,529 | 121,569 |
| Cost of Sales | (160,669) | 58.587% | (101,313) | (83,706) | (57,293) | (44,379) |
| Gross Profit | 251,335 | 18.141% | 212,741 | 200,734 | 156,236 | 77,190 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 5 | -58.333% | 12 | (2) | 0 | 0 | |
| Profit / (Loss) before Taxation | 253,132 | 87.454% | 135,037 | 69,927 | 104,848 | 36,998 | |
| Taxation | (1,372) | -84.076% | (8,616) | (24,682) | (19,651) | (5,728) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (9,459) | 3.945% | (9,100) | (4,629) | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 242,301 | 106.528% | 117,321 | 40,616 | 85,197 | 31,270 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (183,523) | 179.288% | (65,711) | (7,174) | (240) | 213 |
| Depreciation & Amortisation | 9,371 | 4.273% | 8,987 | 6,149 | 5,316 | 4,832 |
| Directors' Emoluments | 10,048 | -24.858% | 13,372 | 11,934 | 2,717 | 3,240 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 33.560 | 104.385% | 16.420 | 6.590 | 15.920 | -- |
| DPS (cts) | 23.150 | -- | 6.540 | 1.700 | -- | -- |
| Dividend Payout Ratio (%) | 68.981% | -- | 39.829% | 25.797% | -- | -- |
| Cash flow per share ($) | 0.141 | -- | 0.108 | 0.072 | 0.208 | -- |
| NBV per share ($) | 6.324 | -- | 6.135 | 5.536 | -- | -- |
| Remarks: | Real time quote last updated: 21/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 146,719,000 |
| %Change | 48.624% |
| EPS / (LPS) | RMB 0.202 |
| NBV Per Share (¥) | RMB 6.439 |